New Studies Moving Ahead to Evaluate Immunosuppressive Response After Positive Data for mRNA to Address Cancers: $RGBP
Advancing Therapies for Treating Cancer and Autoimmune Disorders by Modulating the Immune Checkpoint NR2F6. Regen BioPharma Inc. (OTCMKTS:RGBP) LA MESA, CALIFORNIA, UNITED STATES, November 15, 2023 /EINPresswire.com/ -- New Studies Moving Ahead to …